Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Prognostic Value of MicroRNAs in Patients after Myocardial Infarction: A Substudy of PRAGUE-18.

Hromádka M, Černá V, Pešta M, Kučerová A, Jarkovský J, Rajdl D, Rokyta R, Moťovská Z.

Dis Markers. 2019 Nov 3;2019:2925019. doi: 10.1155/2019/2925019. eCollection 2019.

2.

Stent Thrombosis After ACS-PCI: Does Adherence to Antiplatelet Therapy Involve More Than Its Intensity?

Motovska Z.

Rev Esp Cardiol (Engl Ed). 2019 Apr;72(4):282-284. doi: 10.1016/j.rec.2018.10.011. Epub 2018 Nov 27. Review. English, Spanish. No abstract available.

PMID:
30497947
3.

Reply: Cost of Therapies in Acute Coronary Syndromes: A Relevant Factor Not Reflected in the Trials.

Motovska Z, Hlinomaz O, Kala P.

J Am Coll Cardiol. 2018 Jun 12;71(23):2711-2712. doi: 10.1016/j.jacc.2018.04.002. No abstract available.

4.

12 months of DAPT after acute coronary syndrome still beats 6 months.

Motovska Z, Bhatt DL.

Lancet. 2018 Mar 31;391(10127):1240-1242. doi: 10.1016/S0140-6736(18)30612-3. Epub 2018 Mar 12. No abstract available.

PMID:
29544700
5.

1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor.

Motovska Z, Hlinomaz O, Kala P, Hromadka M, Knot J, Varvarovsky I, Dusek J, Jarkovsky J, Miklik R, Rokyta R, Tousek F, Kramarikova P, Svoboda M, Majtan B, Simek S, Branny M, Mrozek J, Cervinka P, Ostransky J, Widimsky P; PRAGUE-18 Study Group.

J Am Coll Cardiol. 2018 Jan 30;71(4):371-381. doi: 10.1016/j.jacc.2017.11.008. Epub 2017 Nov 14.

6.
7.

Clinical and laboratory predictors of Infectious Complications in patients after Out-of-Hospital Cardiac Arrest.

Kroupa J, Knot J, Ulman J, Bednar F, Dohnalova A, Motovska Z.

J Crit Care. 2017 Dec;42:85-91. doi: 10.1016/j.jcrc.2017.07.010. Epub 2017 Jul 4.

PMID:
28700964
8.

Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 study.

Ondrakova M, Motovska Z, Waldauf P, Knot J, Havluj L, Bittner L, Bartoska R, Gűrlich R, Krbec M, Dzupa V, Grill R, Widimsky P.

PLoS One. 2017 May 24;12(5):e0177519. doi: 10.1371/journal.pone.0177519. eCollection 2017.

9.

Response by Motovska et al to Letter Regarding Article, "Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study".

Motovska Z, Hlinomaz O, Kala P; PRAGUE-18 Investigators.

Circulation. 2017 Apr 11;135(15):e887-e888. doi: 10.1161/CIRCULATIONAHA.117.027476. No abstract available.

PMID:
28396383
10.

THA and TKA in patients with cardiovascular disease: What makes the risk of perioperative bleeding?

Dzupa V, Motovska Z, Widimsky P, Waldauf P, Ondrakova M, Bartoska R, Jezek M, Lena T, Popelka O, Krbec M.

Bratisl Lek Listy. 2016;117(11):628-630. doi: 10.4149/BLL_2016_122.

PMID:
28125887
11.

Characteristics and Survival Determinants in Patients After Out-of-Hospital Cardiac Arrest in The Era of 24/7 Coronary Intervention Facilities.

Kroupa J, Knot J, Ulman J, Bednar F, Dohnalova A, Motovska Z.

Heart Lung Circ. 2017 Aug;26(8):799-807. doi: 10.1016/j.hlc.2016.11.012. Epub 2016 Dec 24.

PMID:
28111177
12.

Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study.

Motovska Z, Hlinomaz O, Miklik R, Hromadka M, Varvarovsky I, Dusek J, Knot J, Jarkovsky J, Kala P, Rokyta R, Tousek F, Kramarikova P, Majtan B, Simek S, Branny M, Mrozek J, Cervinka P, Ostransky J, Widimsky P; PRAGUE-18 Study Group.

Circulation. 2016 Nov 22;134(21):1603-1612. Epub 2016 Aug 30.

PMID:
27576777
13.

CardioPulse: Quality measures in acute coronary syndromes.

Motovska Z.

Eur Heart J. 2016 Jan 14;37(3):209-10. No abstract available.

PMID:
27471759
14.

Risk comparison of bleeding and ischemic perioperative complications after acute and elective orthopedic surgery in patients with cardiovascular disease.

Džupa V, Waldauf P, Moťovská Z, Widimský P, Ondráková M, Bartoška R, Ježek M, Lena T, Popelka O, Krbec M.

Arch Orthop Trauma Surg. 2016 Jul;136(7):907-11. doi: 10.1007/s00402-016-2468-y. Epub 2016 May 5.

PMID:
27146820
15.

The impact of stage of chronic kidney disease on the outcomes of diabetics with acute myocardial infarction treated with percutaneous coronary intervention.

Vichova T, Knot J, Ulman J, Maly M, Motovska Z.

Int Urol Nephrol. 2016 Jul;48(7):1137-43. doi: 10.1007/s11255-016-1260-9. Epub 2016 Mar 19.

PMID:
26995007
16.

Prognostic impact and change of concomitant mitral regurgitation after surgical or transcatheter aortic valve replacement for aortic stenosis.

Fojt R, Moťovská Z, Budera P, Malý M, Straka Z.

J Cardiol. 2016 Jun;67(6):526-30. doi: 10.1016/j.jjcc.2016.02.001. Epub 2016 Mar 11.

17.

Values of osteoprotegerin in aortic valve tissue in patients with significant aortic stenosis depend on the existence of concomitant coronary artery disease.

Fojt R, Pirk J, Kamenický P, Karpíšek M, Straka Z, Malý M, Moťovská Z.

Cardiovasc Pathol. 2016 May-Jun;25(3):181-184. doi: 10.1016/j.carpath.2015.12.003. Epub 2015 Dec 30.

PMID:
26874038
18.

Efficacy of P2Y12 receptor antagonists in patients with atrial fibrillation according to the CHA2DS2VASc score.

Ondrakova M, Knot J, Ulman J, Maly M, Motovska Z.

Int J Cardiol. 2016 Mar 15;207:84-6. doi: 10.1016/j.ijcard.2016.01.039. Epub 2016 Jan 6. No abstract available.

PMID:
26797336
19.

Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction.

Bednar F, Kroupa J, Ondrakova M, Osmancik P, Kopa M, Motovska Z.

J Thromb Thrombolysis. 2016 May;41(4):549-55. doi: 10.1007/s11239-015-1274-7.

PMID:
26340851
20.

Number of severe bleeding complications according to classification used: Is unified classification of bleeding complications really necessary?

Sionova M, Blasko P, Jirous S, Vindis D, Rokyta R, Posch L, Motovska Z.

Cardiol J. 2015;22(6):665-74. doi: 10.5603/CJ.a2015.0044. Epub 2015 Jul 23.

PMID:
26202655
21.

Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel.

Widimsky P, Motovska Z, Bolognese L, Dudek D, Hamm C, Tanguay JF, Ten Berg J, Brown E, LeNarz L, Miller DL, Montalescot G; ACCOAST Investigators.

Heart. 2015 Aug;101(15):1219-24. doi: 10.1136/heartjnl-2015-307686. Epub 2015 Jun 9.

PMID:
26060122
22.

Female sex is associated with delayed reperfusion by percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

Vichova T, Knot J, Waldauf P, Motovska Z.

Pol Arch Med Wewn. 2015;125(6):478-81. Epub 2015 May 15. No abstract available.

23.

Mortality in patients with TIMI 3 flow after PCI in relation to time delay to reperfusion.

Vichova T, Maly M, Ulman J, Motovska Z.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Mar;160(1):118-24. doi: 10.5507/bp.2015.015. Epub 2015 Apr 27.

24.

Selection of P2Y12 antagonist, treatment initiation, and predictors of high on-treatment platelet reactivity in a "Real World" registry.

Motovska Z, Ondrakova M, Bednar F, Knot J, Ulman J, Maly M.

Thromb Res. 2015 Jun;135(6):1093-9. doi: 10.1016/j.thromres.2015.04.014. Epub 2015 Apr 16.

PMID:
25917561
25.
26.

The effect of different doses and different routes of acetylsalicylic acid administration on platelet aggregation in healthy volunteers and ischemic stroke patients.

Chýlová M, Moťovská Z, Osmančík P, Procházka B, Kalvach P.

Transl Stroke Res. 2015 Apr;6(2):160-5. doi: 10.1007/s12975-014-0382-6. Epub 2014 Dec 19.

PMID:
25524214
27.

Perioperative cardiovascular complications versus perioperative bleeding in consecutive patients with known cardiac disease undergoing non-cardiac surgery. Focus on antithrombotic medication. The PRAGUE-14 registry.

Widimský P, Moťovská Z, Havlůj L, Ondráková M, Bartoška R, Bittner L, Dušek L, Džupa V, Knot J, Krbec M, Mencl L, Pachl J, Grill R, Haninec P, Waldauf P, Gürlich R.

Neth Heart J. 2014 Sep;22(9):372-9. doi: 10.1007/s12471-014-0575-3.

28.

Severe left ventricular systolic dysfunction is independently associated with high on-clopidogrel platelet reactivity.

Motovska Z, Ondrakova M, Doktorova M, Widimsky P.

Am J Cardiovasc Drugs. 2014 Aug;14(4):313-8. doi: 10.1007/s40256-014-0074-3.

PMID:
24728851
29.

Transportation to primary percutaneous coronary intervention, compared with on-site fibrinolysis, is a strong independent predictor of functional status after myocardial infarction: 5-year follow-up of the PRAGUE-2 trial.

Mocova Bilkova D, Motovska Z, Prochazka B, Groch L, Zelizko M, Aschermann M, Widimsky P; PRAGUE Study Group Investigators.

Eur Heart J Acute Cardiovasc Care. 2014 Jun;3(2):105-9. doi: 10.1177/2048872613516016. Epub 2013 Dec 4.

PMID:
24337919
31.

Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes.

Montalescot G, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay JF, ten Berg JM, Miller DL, Costigan TM, Goedicke J, Silvain J, Angioli P, Legutko J, Niethammer M, Motovska Z, Jakubowski JA, Cayla G, Visconti LO, Vicaut E, Widimsky P; ACCOAST Investigators.

N Engl J Med. 2013 Sep 12;369(11):999-1010. doi: 10.1056/NEJMoa1308075. Epub 2013 Sep 1.

32.

Oxidative stress: Predictive marker for coronary artery disease.

Vichova T, Motovska Z.

Exp Clin Cardiol. 2013 Spring;18(2):e88-91.

33.

Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: data from the Resolute program.

Widimsky P, Motovska Z, Belardi J, Serruys P, Silber S, Windecker S, Neumann FJ.

Int J Cardiol. 2013 Oct 9;168(4):3522-6. doi: 10.1016/j.ijcard.2013.04.209. Epub 2013 May 22.

PMID:
23706326
34.

Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery disease.

Paulu P, Osmancik P, Tousek P, Minarik M, Benesova L, Motovska Z, Bednar F, Kocka V, Widimsky P.

J Thromb Thrombolysis. 2013 Jul;36(1):1-6. doi: 10.1007/s11239-012-0813-8.

PMID:
23054463
35.

Circulating osteoprotegerin and Dickkopf-1 changed significantly after surgical aortic valve replacement but remained without any significant differences after transcatheter aortic valve implantation.

Motovska Z, Vichova T, Tousek P, Dusek L, Widimsky P.

Int J Cardiol. 2012 Jul 12;158(2):300-1. doi: 10.1016/j.ijcard.2012.04.115. Epub 2012 May 14. No abstract available.

PMID:
22592030
36.

Renal function assessed using cystatin C and antiplatelet efficacy of clopidogrel assessed using the vasodilator-stimulated phosphoprotein index in patients having percutaneous coronary intervention.

Motovska Z, Odvodyova D, Fischerova M, Stepankova S, Maly M, Morawska P, Widimsky P.

Am J Cardiol. 2012 Mar 1;109(5):620-3. doi: 10.1016/j.amjcard.2011.10.019. Epub 2011 Dec 10.

PMID:
22154314
37.

Shock index: a simple clinical parameter for quick mortality risk assessment in acute myocardial infarction.

Bilkova D, Motovska Z, Widimsky P, Dvorak J, Lisa L, Budesinsky T.

Can J Cardiol. 2011 Nov-Dec;27(6):739-42. doi: 10.1016/j.cjca.2011.07.008. Epub 2011 Sep 22.

PMID:
21944278
38.

Management of antiplatelet therapy inpatients at risk for coronary StentThrombosis undergoing non-cardiac surgery.

Motovska Z.

Drugs. 2011 Oct 1;71(14):1797-806. doi: 10.2165/11594260-000000000-00000. Review.

PMID:
21942972
39.

Platelet-derived chemokines, PF-4 and RANTES, are significantly increased in hemodynamically significant degenerative aortic stenosis.

Motovska Z, Odvodyova D, Karpisek M, Hrabakova H, Kocka V, Simkova I, Katina S, Widimsky P.

Int J Cardiol. 2011 Oct 20;152(2):273-5. doi: 10.1016/j.ijcard.2011.08.021. Epub 2011 Sep 3. No abstract available.

PMID:
21893355
40.

Platelet gene polymorphisms and risk of bleeding in patients undergoing elective coronary angiography: a genetic substudy of the PRAGUE-8 trial.

Motovska Z, Kvasnicka J, Hajkova J, Kala P, Simek S, Bobcikova P, Petr R, Bilkova D, Poloczek M, Miklik R, Fischerova M, Maly M, Widimsky P.

Atherosclerosis. 2010 Oct;212(2):548-52. doi: 10.1016/j.atherosclerosis.2010.07.006. Epub 2010 Jul 16.

PMID:
20691446
41.

Stent thrombosis--risk assessment and prevention.

Motovska Z, Knot J, Widimsky P.

Cardiovasc Ther. 2010 Oct;28(5):e92-100. doi: 10.1111/j.1755-5922.2010.00186.x. Epub 2010 Jun 11. Review.

42.

A comparison of the VASP index between patients with hemodynamically complicated and uncomplicated acute myocardial infarction.

Osmancik P, Jirmar R, Hulikova K, Peroutka Z, Pompachova A, Motovska Z, Widimsky P.

Catheter Cardiovasc Interv. 2010 Feb 1;75(2):158-66. doi: 10.1002/ccd.22248.

PMID:
19902490
43.

An embolus in the right atrium caught in the Chiari network and resistant to thrombolysis.

Motovska Z, Widimsky P, Bilkova D, Penicka M, Linkova H, Kautznerova D, Kolesar M, Koldová L, Kvasnicka J.

J Thromb Thrombolysis. 2010 Jul;30(1):114-8. doi: 10.1007/s11239-009-0403-6.

PMID:
19894103
44.

Haematological manifestation of coeliac disease in a young patient with myocardial infarction.

Motovska Z, Widimsky P, Brambaski I, Dvorak M, Julisova I, Kozak T.

Intern Med J. 2009 Oct;39(10):704-6. doi: 10.1111/j.1445-5994.2009.01997.x. No abstract available.

PMID:
19849762
45.

Clopidogrel before elective percutaneous coronary intervention.

Motovska Z, Widimsky P.

J Clin Pharmacol. 2010 Apr;50(4):373-9. doi: 10.1177/0091270009348975. Epub 2009 Sep 29. Review.

PMID:
19789375
46.

Platelet glycoprotein GP VI 13254C allele is an independent risk factor of premature myocardial infarction.

Motovska Z, Kvasnicka J, Widimsky P, Petr R, Hajkova J, Bobcikova P, Osmancik P, Odvodyova D, Katina S.

Thromb Res. 2010 Feb;125(2):e61-4. doi: 10.1016/j.thromres.2009.09.002. Epub 2009 Sep 27.

PMID:
19786296
47.

High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial.

Motovska Z, Widimsky P, Kvasnicka J, Petr R, Bilkova D, Hajkova J, Marinov I, Simek S, Kala P; PRAGUE-8 study investigators.

Blood Coagul Fibrinolysis. 2009 Jun;20(4):257-62.

PMID:
19530321
48.

Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel.

Motovska Z, Widimsky P.

Vasc Health Risk Manag. 2009;5(1):475-81. Review.

49.

Clopidogrel resistance "Live" - the risk of stent thrombosis should be evaluated before procedures.

Motovska Z, Widimsky P, Marinov I, Petr R, Hajkova J, Kvasnicka J; PRAGUE-8 study Investigators.

Thromb J. 2009 May 19;7:6. doi: 10.1186/1477-9560-7-6.

50.

Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox".

Motovska Z, Widimsky P, Petr R, Bilkova D, Marinov I, Simek S, Kala P; PRAGUE-8 Study Investigators.

J Cardiovasc Pharmacol. 2009 May;53(5):368-72. doi: 10.1097/FJC.0b013e31819d616b.

PMID:
19247187

Supplemental Content

Loading ...
Support Center